Author
Listed:
- Juan Pablo Lopez
(McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University)
- Laura M. Fiori
(McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University)
- Cristiana Cruceanu
(McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University)
- Rixing Lin
(McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University)
- Benoit Labonte
(Icahn School of Medicine at Mount Sinai)
- Hannah M. Cates
(Icahn School of Medicine at Mount Sinai)
- Elizabeth A. Heller
(Icahn School of Medicine at Mount Sinai)
- Vincent Vialou
(Icahn School of Medicine at Mount Sinai)
- Stacy M. Ku
(Icahn School of Medicine at Mount Sinai)
- Christophe Gerald
(Icahn School of Medicine at Mount Sinai)
- Ming-Hu Han
(Icahn School of Medicine at Mount Sinai)
- Jane Foster
(University Health Network, University of Toronto)
- Benicio N. Frey
(McMaster University and St Joseph’s Healthcare Hamilton)
- Claudio N. Soares
(St Michael’s Hospital
Queen’s University)
- Daniel J. Müller
(University Health Network, University of Toronto
Centre for Addiction and Mental Health)
- Faranak Farzan
(University Health Network, University of Toronto
Centre for Addiction and Mental Health
School of Mechatronic Systems Engineering)
- Francesco Leri
(University of Guelph)
- Glenda M. MacQueen
(University of Calgary Hotchkiss Brain Institute)
- Harriet Feilotter
(Queen’s University)
- Kathrin Tyryshkin
(Queen’s University)
- Kenneth R. Evans
(Queen’s University
Indoc Research)
- Peter Giacobbe
(University Health Network, University of Toronto)
- Pierre Blier
(University of Ottawa Institute of Mental Health Research)
- Raymond W. Lam
(University of British Columbia and Vancouver Coastal Health Authority)
- Roumen Milev
(Queen’s University, Providence Care, Mental Health Services)
- Sagar V. Parikh
(University of Michigan)
- Susan Rotzinger
(University Health Network, University of Toronto)
- Steven C. Strother
(Rotman Research Institute at Baycrest Centre)
- Cathryn M. Lewis
(MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London)
- Katherine J. Aitchison
(University of Alberta
Dalhousie University)
- Gayle M. Wittenberg
(Janssen Research & Development, LLC)
- Naguib Mechawar
(McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University)
- Eric J. Nestler
(Icahn School of Medicine at Mount Sinai)
- Rudolf Uher
(MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London
Dalhousie University)
- Sidney H. Kennedy
(University Health Network, University of Toronto)
- Gustavo Turecki
(McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University)
Abstract
Antidepressants (ADs) are the most common treatment for major depressive disorder (MDD). However, only ∼30% of patients experience adequate response after a single AD trial, and this variability remains poorly understood. Here, we investigated microRNAs (miRNAs) as biomarkers of AD response using small RNA-sequencing in paired samples from MDD patients enrolled in a large, randomized placebo-controlled trial of duloxetine collected before and 8 weeks after treatment. Our results revealed differential expression of miR-146a-5p, miR-146b-5p, miR-425-3p and miR-24-3p according to treatment response. These results were replicated in two independent clinical trials of MDD, a well-characterized animal model of depression, and post-mortem human brains. Furthermore, using a combination of bioinformatics, mRNA studies and functional in vitro experiments, we showed significant dysregulation of genes involved in MAPK/Wnt signalling pathways. Together, our results indicate that these miRNAs are consistent markers of treatment response and regulators of the MAPK/Wnt systems.
Suggested Citation
Juan Pablo Lopez & Laura M. Fiori & Cristiana Cruceanu & Rixing Lin & Benoit Labonte & Hannah M. Cates & Elizabeth A. Heller & Vincent Vialou & Stacy M. Ku & Christophe Gerald & Ming-Hu Han & Jane Fos, 2017.
"MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes,"
Nature Communications, Nature, vol. 8(1), pages 1-12, August.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15497
DOI: 10.1038/ncomms15497
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15497. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.